• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

H1

H1 Launches Advanced Diversity and Clinical Trial Performance Insights

by Syed Hamza Sohail 03/13/2023 Leave a Comment

H1 Launches Advanced Diversity and Clinical Trial Performance Insights

What You Should Know: - H1, the connecting force for global healthcare provider, clinical, science, and research information, today announced the availability of indication-level diversity insights in addition to institution, provider, and patient diversity data within its Trial Landscape solution. - Additionally, H1 has successfully onboarded its first customer – a top 20 pharmaceutical company – onto the H1 Data Network, a new solution that aggregates sponsor-contributed site and
Read More

22 Executive Digital Health Predictions to Watch in 2023

by Fred Pennic 01/16/2023 Leave a Comment

22 Executive Digital Health Predictions to Watch in 2023

Jon Bloom, MD, CEO and Co-founder of Podimetrics From a digital health perspective, 2022 was a reset year for many and a serious reality check. We went from sky high growth to the sky is falling, and in 2023 I think this market correction movement will continue forward. To me, the biggest surprise of 2022 was that despite the market tanking, digital health companies continued to truck forward with huge deals. This includes massive acquisitions like Amazon and OneMedical, as well as deals like
Read More

7 Life Sciences Executive Predictions to Watch in 2023

by Fred Pennic 01/13/2023 Leave a Comment

7 Executive Life Sciences Predictions to Watch in 2023

Tracy Curley, CFO and interim CEO at iSpecimen Focusing on the macroeconomic environment, which remains impacted by the lingering COVID-19 pandemic, there continues to be uncertainty about the strength of the global, Asia Pacific, UK and US economies. High-interest rates and a potential recession remain a concern for all market participants. At ISPC, we are closely monitoring the pace of specimen transactions. We believe that this industry can be resilient through a continued economic
Read More

20 Executives Share Health IT Predictions to Watch in 2023

by Fred Pennic 01/11/2023 Leave a Comment

20 Executives Share Health IT Predictions to Watch in 2023

We asked several healthcare executives to share their health IT predictions and trends for 2023. Nate Maslak, the co-founder/CEO of Ribbon Health Data Personalization: 38% of consumers want more personalized and inclusive healthcare options. In 2023, we’ll see a greater shift towards healthcare enterprises prioritizing this personalization, by innovating their current data infrastructure to show a range of information that lets a patient make an educated care decision based on what
Read More

2022 Healthcare Investment, M&A, IPO Market Trends/Insights

by Syed Hamza Sohail 01/10/2023 Leave a Comment

2022 Healthcare Investment, M&A, IPO Market Highlights/Trends

What You Should Know: - The latest edition of SVB's Healthcare Investments and Exits report provides information on VC fundraising, investments and M&A and IPO trends - along with subsector analysis and video commentary for each. - Healthcare trends indicate US healthcare VC investment was healthy in 2022 despite an economic downturn. There's plenty of dry powder to deploy; however, investments and exits are slowing due to the volatile market. Trends and Insights – Healthcare
Read More

How AI-Based Drug Repurposing Could Help Prevent Repetitive Behavior Disorders

by Jinhan Kim, Co-founder and CEO, Standigm 11/30/2022 Leave a Comment

How AI-Based Drug Repurposing Could help Prevent Repetitive Behavior Disorders

Repetitive behavioral disorders such as obsessive-compulsive disorder (OCD), Tic Disorder and Tourette Syndrome have been challenging to treat because they involve considerable complexity. For example, the symptoms of one disorder can vary among individuals as does the coexistence or non-existence of other behavior disorders such as anxiety and depression. Further, the treatment of OCD, Tic Disorder and Tourette Syndrome varies depending on
Read More

H1 Launches AI-Powered and Evidence-Based Interactions

by Syed Hamza Sohail 08/11/2022 Leave a Comment

H1 Launches AI-Powered and Evidence-Based Interactions

What You Should Know: - H1, launches an update to its flagship product, HCP Universe, the daily resource for global medical affairs and medical science liaison (MSL) teams. - New features include a mobile app, Next-gen Smart Search capabilities built on an expansive knowledge graph, out-of-the-box insights tailored to inform MSL and Headquarter decisioning, and AI-powered notifications to improve and accelerate quality HCP engagement.  Establishing AI-Driven Efficient Workflows H1 is
Read More

H1 & Lokavant Partner to Power Next-Gen Clinical Trials

by Syed Hamza Sohail 08/03/2022 Leave a Comment

H1 & Lokavant Partner to Power Next-Gen Clinical Trials

What You Should Know: - H1and Lokavant today announced an extensive data-and-analytics collaboration to bring enhanced automated intelligence to drug development - As part of the bi-directional partnership, Lokavant will provide performance data on global trial sites and principal investigators from thousands of studies to supplement H1’s existing Trial Landscape clinical trial repository.  Integrating Clinical Trial Data Sources to Intelligence Platforms Lokavant is a clinical
Read More

Can We Reach Health 4.0 in the Next 3-5 Years?

by Syed Hamza Sohail 08/01/2022 Leave a Comment

Can We Reach Health 4.0 in the Next 3-5 Years?

What You Should Know: - According to a new report from Allison + Partners, 57% of respondents said it will be possible to achieve “Health 4.0” in the next 3-5 years - The report illustrates that the biggest hurdles include legislative and regulatory policy, lack of tech talent, and little understanding of health technologies and that the opportunities outweigh the challenges Health 4.0: Barriers and Solutions During the pandemic, there was a record-breaking infusion of capital into
Read More

H1 Adds $20M to Series C to Power Democratization of Global Healthcare Data

by Jasmine Pennic 06/09/2022 Leave a Comment

H1 Raises $100M to Expand Healthcare Professional Data Network

What You Should Know: - H1, the connecting force for global healthcare professional, clinical, science, and research information, announced their Series C extension led by Goldman Sachs Asset Management, Menlo Ventures, Transformation Capital and Novartis Pharma AG, bringing the total Series C raise to over $120M.  - The news comes at a time when public markets are down and many other companies are doing down rounds. The extension allows H1’s valuation of $773M to stay constant,
Read More

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Next Page

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |